US Patent 11530237 Compositions and methods for treating CNS disorders
Patent 11530237 was granted and assigned to SAGE Therapeutics on December, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 14 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Apr, 2023
Golden AI
Infobox
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115302370
Date of Patent
December 20, 2022
0Patent Application Number
167481170
Date Filed
January 21, 2020
0Patent Primary Examiner
Edits on 21 Dec, 2022
Golden AI
Edits made to:
Infobox (+23 properties)
US Patent 11530237 Compositions and methods for treating CNS disorders
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115302370
Date of Patent
December 20, 2022
0Patent Application Number
167481170
Date Filed
January 21, 2020
0Patent Primary Examiner
Find more entities like US Patent 11530237 Compositions and methods for treating CNS disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
